{"id":50574,"date":"2022-11-07T22:02:13","date_gmt":"2022-11-07T21:02:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/"},"modified":"2022-11-07T22:02:13","modified_gmt":"2022-11-07T21:02:13","slug":"foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/","title":{"rendered":"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT"},"content":{"rendered":"
\n

MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc.<\/a> (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that it will report financial results for the third quarter ended September 30, 2022 after market closes on Monday, November 14, 2022.\n<\/p>\n

<\/a><\/p>\n

\nManagement will host a conference call to discuss third quarter results and recent business highlights at 3:15 p.m. Central time on Monday, November 14, 2022.\n<\/p>\n

\nThe call can be accessed via webcast<\/a> on the investors section of the Company\u2019s website at www.foxotechnologies.com\/investors<\/a> or by dialing (888) 770-7136 and referencing conference ID 4335886. Participants are encouraged to call in 10 to 15 minutes prior to the scheduled start time.\n<\/p>\n

\nThe webcast will be made available for replay on the Company\u2019s website beginning approximately two hours after the event.\n<\/p>\n

\nAbout FOXO Technologies Inc. (\u201cFOXO\u201d)<\/b>\n<\/p>\n

\nFOXO is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO’s epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. FOXO seeks to modernize the life insurance industry by simplifying the consumer underwriting journey with saliva-based biomarkers and enhancing life insurance\u2019s consumer value proposition with the FOXO Longevity Report. For more information about FOXO, visit www.foxotechnologies.com<\/a>. For more information about FOXO Life, visit www.foxolife.com<\/a>. For investor information and updates, visit https:\/\/foxotechnologies.com\/investors\/<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations<\/b>
Cody Slach, Matthew Hausch
\n
Gateway Investor Relations
\n
(949) 574-3860
\n
FOXO@gatewayir.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that it will report financial results for the third quarter ended September 30, 2022 after market closes on Monday, November 14, 2022. Management will … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50574","6":"format-standard","7":"category-industry"},"yoast_head":"\nFOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that it will report financial results for the third quarter ended September 30, 2022 after market closes on Monday, November 14, 2022. Management will ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-07T21:02:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221104005530\/en\/1626365\/21\/FOXO-Black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT\",\"datePublished\":\"2022-11-07T21:02:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/\"},\"wordCount\":269,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005530\\\/en\\\/1626365\\\/21\\\/FOXO-Black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/\",\"name\":\"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005530\\\/en\\\/1626365\\\/21\\\/FOXO-Black.jpg\",\"datePublished\":\"2022-11-07T21:02:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005530\\\/en\\\/1626365\\\/21\\\/FOXO-Black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005530\\\/en\\\/1626365\\\/21\\\/FOXO-Black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/","og_locale":"en_US","og_type":"article","og_title":"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT - Pharma Trend","og_description":"MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that it will report financial results for the third quarter ended September 30, 2022 after market closes on Monday, November 14, 2022. Management will ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-07T21:02:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221104005530\/en\/1626365\/21\/FOXO-Black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT","datePublished":"2022-11-07T21:02:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/"},"wordCount":269,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221104005530\/en\/1626365\/21\/FOXO-Black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/","url":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/","name":"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221104005530\/en\/1626365\/21\/FOXO-Black.jpg","datePublished":"2022-11-07T21:02:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221104005530\/en\/1626365\/21\/FOXO-Black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221104005530\/en\/1626365\/21\/FOXO-Black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-inc-sets-third-quarter-2022-earnings-call-for-monday-november-14-2022-at-315-p-m-ct\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50574"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50574\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}